Johnson & Johnson Faces Legal Setback in Landmark Talc Case
Published on 12/15/2025 at 05:42 | Redaktion boerse-global.de
A California jury has delivered a significant legal blow to Johnson & Johnson, ordering the healthcare giant to pay $40 million in damages in a talc-related cancer lawsuit. This verdict, reached on Friday, December 12, 2025, represents the first plaintiff victory against the company since 2021, reigniting concerns over its long-running litigation saga.
Jurors at the Los Angeles Superior Court awarded $18 million to plaintiff Monica Kent and $22 million to Deborah Schultz and her husband. Both women attributed their ovarian cancer diagnoses to the prolonged use of Johnson & Johnson’s talc-based baby powder.
In a swift response, the company labeled the decision an “aberrant adverse verdict” and announced its immediate intention to appeal. Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
